ABRI — Miami, Florida

ABRI is a clinical research site located in Miami, Florida, United States 33155.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

ABRI has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Attention Deficit/Hyperactivity Disorder.

Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for ABRI?

ABRI has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has ABRI conducted?

ABRI has 1 clinical trials on record, with 1 currently active. Their work covers Attention Deficit/Hyperactivity Disorder.

Is ABRI accredited by Crixeo Health?

ABRI has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about ABRI?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.